MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-24-0012743
Beref Pharmaceuticals Private Limited
Beref Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. Directors, charges & compliance details.
Revenue · FY 2025
₹14.86 Cr
▲ 36% YoY
Net profit · FY 2025
₹1.04 Cr
Net margin 7%
EBITDA · FY 2025
₹1.91 Cr
EBITDA margin 12.8%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹2.89 Cr
Issued & subscribed
Open charges
₹3.51 Cr
Satisfied ₹60 Lakh
Company age
5 yrs
Est. 2021
Employees · EPFO
19
Provident fund records
About Beref Pharmaceuticals Private Limited
Data last updated:
Beref Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24299TN2021PTC140503.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹2.89 Cr. It is led by directors including Karuppiah Murugupandian (Managing Director) and Vinayagam Senthil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.86 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹1.04 Cr (net margin 7%) and EBITDA of ₹1.91 Cr (EBITDA margin 12.8%).
The company has about 19 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3.51 Cr and satisfied charges of ₹60 Lakh on record.
Beref Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-24-0012743).
Company details
CIN U24299TN2021PTC140503
Registration Number 140503
Incorporation Date 02 January 2021
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-TN-24-0012743
Key People
Karuppiah Murugupandian Managing Director Vinayagam Senthil Director Raju Ramamoorthy Director Recognitions & Rankings of Beref Pharmaceuticals
Contact details
Beref Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressPlot No. 3, Shridi Sai Nagar Extension, Chennai, Tamil Nadu, India – 600056
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Beref Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Beref Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Beref Pharmaceuticals Private Limited, buy the company report.
Financials of Beref Pharmaceuticals Private Limited
FY 2025 filings availableBeref Pharmaceuticals Private Limited reported revenue of ₹14.86 Cr (up 36% YoY) for FY 2025.
Revenue · FY 2025
₹14.86 Cr ▲ 36%
Net profit · FY 2025
₹1.04 Cr margin 7%
EBITDA · FY 2025
₹1.91 Cr margin 12.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 36%
EBITDA CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 89%
Revenue rose 36% in the latest year. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.91 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.04 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.8% | ||||
| Net Profit Margin | 7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Beref Pharmaceuticals Private Limited, buy the company report.
Board of directors of Beref Pharmaceuticals Private Limited
Beref Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinayagam Senthil | Director | 08 Dec 2022 | 3 Years 10 Months | Current |
| Karuppiah Murugupandian | Managing Director | 02 Jan 2021 | 5 Years 10 Months | Current |
| Raju Ramamoorthy | Director | 02 Jan 2021 | 5 Years 10 Months | Current |
Peer comparison
Beref Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eumark Pharmaceuticals Pvt Ltd | ₹15.13 Cr (FY 2025) | 16.0% | Ambernath, Maharashtra, India | |||
| Kras Pharmaceuticals Private Limited | ₹15.05 Cr (FY 2025) | 45.0% | Fatuha, Bihar, India | |||
| Grindlays Pharmaceuticals Pvt Ltd | ₹14.96 Cr (FY 2025) | 69.0% | Mumbai, Maharashtra, India | |||
| Raymed Pharmaceuticals Limited | ₹14.9 Cr (FY 2025) | -2.0% | Chandigarh, India | |||
| Beref Pharmaceuticals Private Limitedthis company | ₹14.86 Cr (FY 2025) | ₹1.04 Cr | 7% | 36.0% | Chennai, Tamil Nadu, India | |
| Malook Pharmaceuticals Private Limited | ₹14.85 Cr (FY 2025) | 55.0% | New Delhi, Delhi, India | |||
| Salve Pharmaceuticals Private Limited | ₹14.84 Cr (FY 2025) | 10.0% | New Delhi, Delhi, India |
To see the full peer comparison of Beref Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.51 Cr
Satisfied charges
₹60 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jan 2026 | 101213830 | Canara Bank | ₹1 Cr | Open | |
| 24 Dec 2024 | 101026895 | Others | ₹76 Lakh | Open | |
| 19 Aug 2021 | 100480461 | Others | ₹1.75 Cr | Open | |
| 25 Apr 2023 | 100713563 | Others | ₹60 Lakh | Satisfied |
To see the full charge records of Beref Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Beref Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Beref Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Beref Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Beref Pharmaceuticals Private Limited has 5 board changes on record since 2021: 3 appointments and 2 cessations. The latest: Vinayagam Senthil ceased to be Additional Director on 29 Sep 2023.
Charges
A charge with Canara Bank amounted to Rs. 1.00 Cr with Charge ID 101213830 was registered on 02 Jan 2026.
Charges
A charge registered on 25 Apr 2023 via Charge ID 100713563 with Others was fully satisfied on 08 Dec 2025.
AGM
Beref Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Beref Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Others amounted to Rs. 0.76 Cr with Charge ID 101026895 was registered on 24 Dec 2024.
Ceased
Vinayagam Senthil ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 0.60 Cr with Charge ID 100713563 was registered on 25 Apr 2023.
Appointed
Vinayagam Senthil was appointed as Director.
Ceased
Karuppiah Murugupandian ceased to be Director.
Charges
A charge with Others amounted to Rs. 1.75 Cr with Charge ID 100480461 was registered on 19 Aug 2021.
Appointed
Karuppiah Murugupandian was appointed as Managing Director.
Appointed
Raju Ramamoorthy was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Beref Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 January 2021 (5+ years old) and is registered under CIN U24299TN2021PTC140503.
Beref Pharmaceuticals has 3 current directors:
- Karuppiah Murugupandian - Managing Director
- Vinayagam Senthil - Director
- Raju Ramamoorthy - Director
The latest financial statements of Beref Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Beref Pharmaceuticals is U24299TN2021PTC140503. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Beref Pharmaceuticals was incorporated on 02 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Beref Pharmaceuticals by revenue are Eumark Pharmaceuticals Pvt Ltd, Kras Pharmaceuticals Private Limited, Grindlays Pharmaceuticals Pvt Ltd, Raymed Pharmaceuticals Limited, Malook Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vinayagam Senthil ceased to be Additional Director on 29 Sep 2023. Vinayagam Senthil was appointed as Director on 08 Dec 2022. Karuppiah Murugupandian ceased to be Director on 20 Oct 2021. Beref Pharmaceuticals has 5 board changes on record in total.
Yes, Beref Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TN-24-0012743).
The registered office of Beref Pharmaceuticals is at Plot No. 3, Shridi Sai Nagar Extension, Chennai, Tamil Nadu, India – 600056.
Beref Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Beref Pharmaceuticals has open charges of ₹3.51 Cr and satisfied charges of ₹60 Lakh as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages